Navigation Links
Cumberland Pharmaceuticals Reports Second Quarter 2012 Financial Results
Date:8/2/2012

p>

1,999,2853,604,5132,695,1544,839,380Income tax expense

(263,031)(1,436,365)(545,059)(1,959,949)Net and comprehensive income

1,736,2542,168,1482,150,0952,879,431Net loss attributableto noncontrolling interests

8,0369,47117,40319,348Net income attributable tocommon shareholders

$
,744,290$   2,177,619$
2,167,498$
2,898,779Earnings per share attributable to common shareholders- basic

$
.09$
.11$
.11$
.14- diluted

$
.09$
.11$
.11$
.14Weighted-average shares outstanding- basic

19,771,16720,471,62119,889,58320,458,842- diluted

19,996,80520,661,71920,117,24620,719,714 

 

CUMBERLAND PHARMACEUTICALS INC. AND SUBSIDIARIESCondensed Consolidated Statements of Cash Flows(Unaudited) Six Months Ended June 30,20122011Cash flows from operating activities:Net income

$
2,150,095$
2,879,431Adjustments to reconcile net income to net cash flows from operating activities:Depreciation and amortization expense

441,199527,301Stock-based compensation - nonemployees

75,44444,574Stock-based compensation - employees

315,344315,513Excess tax benefit derived from exercise of stock options

(854,988)(1,516,569)Noncash interest expense

12,038123,654Net unrealized investment gains

(34,604)-Net changes in assets and liabilities affecting operating activities:Accounts receivable

2,091,278325,760Inventory

(1,541,912)230,591Other current assets and other assets

(173,889)704Accounts payable and other accrued liabilities

1,362,3852,009,529Other long-term liabilities

(596,911)(5,141)Net cash provided by operating activities

3,245,4794,935,347Cash flows from investing activities:Additions to property and equipment

(178,886)(105,838)Purchases of marketable securities

(18,356,482)-Proceeds from marketable securities


'/>"/>

SOURCE Cumberland Pharmaceuticals Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Cumberland Pharmaceuticals To Announce Second Quarter 2012 Financial Results On August 2, 2012
2. Cumberland Pharmaceuticals To Present At The 2012 Wells Fargo Securities Healthcare Conference In Boston
3. Cumberland Pharmaceuticals Reports First Quarter 2012 Financial Results
4. Arena Pharmaceuticals to Host Business and Financial Update Conference Call and Webcast on Thursday, August 9
5. Global Pharmaceuticals Market 2011-2015
6. Onyx Pharmaceuticals Reports Second Quarter 2012 Financial Results
7. MAP Pharmaceuticals, Inc. Prices Public Offering of Common Stock
8. Avanir Pharmaceuticals Announces Date Of Fiscal 2012 Third Quarter Financial Results And Conference Call
9. AcelRx Pharmaceuticals Receives Two Additional U.S. Patents for Small-Volume Oral Transmucosal Dosage Forms
10. Actinium Pharmaceuticals Announces The Addition of The Fred Hutchinson Cancer Research Center To Actiniums Multicenter Clinical Trial For Patients With Acute Myeloid Leukemia
11. Synergy Pharmaceuticals to Present Scientific Posters at the Upcoming Gastroenterology Society Meetings in the U.S. and Europe
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2013)... FRANCISCO , May 21, 2013 ... of the American Psychiatric Association show that the ... and clinically meaningful response and remission in patients ... phase of therapy, which were maintained through one ... treatment, 62 percent of patients achieved symptomatic improvement ...
(Date:5/21/2013)... 21 de mayo de 2013 La junta ... filiales incluyen OMNIlife science®, Inc., Enztec, Ltd. y Praxim, ... su junta. Guy Mayer, un ejecutivo ortopédico experimentado, será ... David Johnson , un experto refutado en ... Antes de unirse a OSI como presidente de ...
(Date:5/21/2013)... N.J. , May 21, 2013 ... company, today announced that 13-year veteran ... Executive Officer. Geraghty,s experience includes more than 20 ... management positions with manufacturing organizations. He succeeds ... after serving as Kepner-Tregoe,s Chairman of the Board ...
Breaking Medicine Technology:New Data Show Long-Term Benefit of Transcranial Magnetic Stimulation in Difficult-to-Treat Patients with Depression using NeuroStar TMS Therapy System 2New Data Show Long-Term Benefit of Transcranial Magnetic Stimulation in Difficult-to-Treat Patients with Depression using NeuroStar TMS Therapy System 3New Data Show Long-Term Benefit of Transcranial Magnetic Stimulation in Difficult-to-Treat Patients with Depression using NeuroStar TMS Therapy System 4Orthopaedic Synergy, Inc. anuncia nuevas incorporaciones a la junta directiva 2Orthopaedic Synergy, Inc. anuncia nuevas incorporaciones a la junta directiva 3Kepner-Tregoe, Inc. Promotes Chris Geraghty to Chief Executive Officer 2Kepner-Tregoe, Inc. Promotes Chris Geraghty to Chief Executive Officer 3
... 2007 /PRNewswire-FirstCall/ -- Metabasis,Therapeutics, Inc. announced today that ... the Safety, Tolerability and Pharmacokinetics,(PK) of Intravenous (IV) ... (HCC)" will be presented at,the 2007 annual meeting ... Los Angeles, CA. The presentation will take,place on ...
... 26, 2007 - A study comparing,the formulations of ... I and V-HeFT II, and BiDil, the proprietary,fixed ... Failure,Trial (A-HeFT) demonstrated no bioequivalence. Non-bioequivalence,in the formulations ... II,showed very different results in decreasing mortality. Using,identical ...
Cached Medicine Technology:Metabasis Therapeutics to Present Poster at American Association,for Cancer Research 2Study: Identical Doses of BiDil Components Are Not Bioequivalent to,the Fixed Dose Combination-BiDil-Used in A-HeFT 2Study: Identical Doses of BiDil Components Are Not Bioequivalent to,the Fixed Dose Combination-BiDil-Used in A-HeFT 3Study: Identical Doses of BiDil Components Are Not Bioequivalent to,the Fixed Dose Combination-BiDil-Used in A-HeFT 4Study: Identical Doses of BiDil Components Are Not Bioequivalent to,the Fixed Dose Combination-BiDil-Used in A-HeFT 5
(Date:5/21/2013)... May 21, 2013 Daily Gossip Magazine published ... their readers and keep people informed on the latest weight ... reporters have prepared an in-depth review of Kyle ... useful for readers who want to lose weight or stay ... Daily Gossip the program was created by a popular fitness ...
(Date:5/21/2013)... 2013 Parker Waichman LLP, a national law ... defective medical devices, is offering remarks on the closing argument ... of Fred E. Taylor v. Intuitive Surgical, 09-2-03136-5, Superior Court, ... 2013, Bloomberg report noted that the plaintiff’s attorney, ... dealership” in how it deployed its strategy to train doctors ...
(Date:5/21/2013)... York (PRWEB) May 21, 2013 Parker ... the rights of victims injured by defective medical devices, ... Bone & Joint Surgery on May 15, 2013. The ... used to identify complications that occur in patients with ... of failure. ( http://www.jbjs.org/article.aspx?articleid=1684770 ) , ...
(Date:5/21/2013)... results from SOURCE XT one of the largest, ... reported today at EuroPCR 2013 show good clinical outcomes ... success for all access approaches, valve sizes and delivery ... 2688 consecutively enrolled patients (mean age 81.5 years) undergoing ... centres in 17 countries between July 2010 and October ...
(Date:5/21/2013)... The federal judge overseeing the litigation ... lawsuits in U.S. District Court, Northern District of Georgia, ... from Plaintiffs’ Counsel to conduct Ex Parte interviews with ... Order grants that request, and sets forth procedures under ... Medical Technology, Inc., Conserve Hip Implant Products Liability Litigation, ...
Breaking Medicine News(10 mins):Health News:Customized Fat Loss Plan Review and Diet Secrets Revealed By Daily Gossip Magazine 2Health News:Da Vinci Robotic Surgery Lawsuit: Parker Waichman LLP Reacts to Plaintiff’s Attorney’s Closing Argument in Which He Describes Intuitive Surgical as a Car Dealership 2Health News:Da Vinci Robotic Surgery Lawsuit: Parker Waichman LLP Reacts to Plaintiff’s Attorney’s Closing Argument in Which He Describes Intuitive Surgical as a Car Dealership 3Health News:Parker Waichman LLP Comments on New Study Showing that MRI is Useful for Predicting Failure of Metal-on-Metal Hip Implants 2Health News:Parker Waichman LLP Comments on New Study Showing that MRI is Useful for Predicting Failure of Metal-on-Metal Hip Implants 3Health News:Wright Hip Lawsuit News: Bernstein Liebhard LLP Notes Issuance of New Order in Federal Wright Conserve Hip Replacement Litigation 2Health News:Wright Hip Lawsuit News: Bernstein Liebhard LLP Notes Issuance of New Order in Federal Wright Conserve Hip Replacement Litigation 3
... BETHESDA, Md., Aug. 19 /PRNewswire-Asia/ -- Chindex ... independent American provider of Western,healthcare products and services in ... entered into a contract to supply EUR5 million in,laboratory ... China,s,Qinghai Province. The purchase is being financed by the ...
... , ELM GROVE, Wis., Aug. 19 A webinar on JCAHO ... partment Core Measures: A c hieving Successful Quality Outcomes ... to aid Hospital Emergency Departments in instituting treatment standards as ... CAP patients. Compliance with JCAHO Core Measures produces better outcomes for ...
... warn of toxic buildup from paraffin, suggest beeswax instead ... candles, used mainly for romantic ambiance, fragrance and light, ... , The candles, which are made from petroleum, are ... researchers said in a study to be presented Wednesday ...
... , WASHINGTON, Aug. 19 The ... Tobacco-Free Kids: , , (Logo: http://www.newscom.com/cgi-bin/prnh/20080918/CFTFKLOGO ... and Drug Administration announcement today that it is establishing the Center ... highly respected and experienced public health leader, as the Center Director ...
... , , , ... and Prevention (CDC)(1) and LYSOL(R) brand products are proud to announce the launch ... www.oop k i ds.com , an interactive site ... was created in a continued effort to educate children and their parents about ...
... workers, new federal guidelines say , WEDNESDAY, Aug. 19 ... keeping employees six-feet apart are all ways to reduce ... America,s businesses, government experts said in new guidelines issued ... as the fall/winter flu season approaches, because the extent ...
Cached Medicine News:Health News:Chindex International, Inc. Announces New CDC Contract 2Health News:Chindex International, Inc. Announces New CDC Contract 3Health News:Compirion Hosts Free Webinar on Achieving JCAHO-Compliant Quality Outcomes 2Health News:Compirion Hosts Free Webinar on Achieving JCAHO-Compliant Quality Outcomes 3Health News:Tobacco-Free Kids Welcomes Formation of FDA's Center for Tobacco Products and Selection of Center Director 2Health News:The CDC and Lysol Partner to Educate Kids About How to Help Protect Themselves From Harmful Germs 2Health News:The CDC and Lysol Partner to Educate Kids About How to Help Protect Themselves From Harmful Germs 3Health News:The CDC and Lysol Partner to Educate Kids About How to Help Protect Themselves From Harmful Germs 4Health News:Businesses Need Swine Flu Action Plan: Experts 2Health News:Businesses Need Swine Flu Action Plan: Experts 3
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
Medicine Products: